ABSTRACT
AIM: Questions about care practices and the role of palliative care in pediatric neurodegenerative diseases have led the Neuromuscular Committee of the French Society of Neurology to conduct a retrospective study in spinal muscular atrophy type 1, a genetic disease most often leading to death before the age of 1 year. MATERIAL AND METHODS: A retrospective multicenter study from pediatricians included in the reference centers of pediatric neuromuscular diseases was carried out on two 10-year periods (1989-1998 and 1999-2009). RESULTS: The 1989-1998 period included 12 centers with 106 patients, the 1999-2009 period 13 centers with 116 children. The mean age of onset of clinical signs was 2.1 months (range, 0-5.5 months), the median age at diagnosis was 4 months (range, 0-9 months) vs 3 months. The median age of death was 7.5 months (range, 0-24 months) vs 6 months. The care modalities included physiotherapy (90 %), motor support (61 % vs 26 % for the previous period), enteral nutrition by nasogastric tube (52 % vs 24 %), and 3.4 % of children had a gastrostomy (vs 1.8 %). At home, pharyngeal aspiration was used in 64 % (vs 41 %), oxygen therapy in 8 %, noninvasive ventilatory support in 7 %. The mean age at death was 8.1 months (range, 0-24 months) vs 7 months, the time from diagnosis to death was 4 months vs 3 months. Death occurred at home in 23 % vs 17 %, in a pediatric unit in 62 % vs 41 %. The use of analgesics and sedative drugs was reported in 60 % of cases: 40 % morphine (vs 18 %) and benzodiazepines in 48 % (vs 29 %). Respiratory support was limited mostly to oxygen by nasal tube (55 % vs 54 %), noninvasive ventilation in 9 % of the cases, and intubation and assisted mechanical ventilation (2 %). DISCUSSION AND CONCLUSION: These results confirm a change in practices and the development of palliative care in children with a French consensus of practices quite different from the standard care in North-America and closer to the thinking of English medical teams. A prospective study within the 2011 national hospital clinical research program (PHRC 2011) is beginning in order to evaluate practices and the role of families and caregivers.
Subject(s)
Palliative Care , Spinal Muscular Atrophies of Childhood/therapy , Enteral Nutrition/methods , Exercise Therapy , Female , France , Gastrostomy , Humans , Infant , Infant, Newborn , Male , Noninvasive Ventilation , Oxygen Inhalation Therapy , Palliative Care/methods , Retrospective Studies , Spinal Muscular Atrophies of Childhood/diagnosis , Spinal Muscular Atrophies of Childhood/mortality , Survival AnalysisABSTRACT
Collagen VI-related myopathies are hereditary disorders causing progressive restrictive respiratory insufficiency. Specific diaphragm involvement has been suggested by a drop in supine volumes. This pilot study aimed at characterizing the respiratory muscle phenotype in patients with COL6A1-3 genes mutations. Lung function, blood gases, muscle strength and respiratory mechanics were measured in 7 patients between 2002 and 2012. Patients were classified as Early-Severe (n = 3), Moderate-Progressive (n = 2) and Mild (n = 2) according to clinical disease presentation. Seven patients (aged 6-28) were evaluated. Forced vital capacity distinguished the Mild group (>60% predicted) from the two other groups (<50% predicted). This distinction was also possible using the motor function measure scale. Diaphragmatic dysfunction at rest was observed in all the Early-Severe and Moderate-Progressive patients. During a voluntary sniff maneuver diaphragmatic dysfunction was observed in all patients, as assessed by a negative gastric pressure. All patients had diaphragmatic fatigue assessed by a tension-time index over the threshold of 0.15. Diaphragmatic dysfunction during a maximal voluntary maneuver and diaphragmatic fatigue are constant features in Collagen VI myopathies. These observations can assist the diagnosis and should be taken in account for the clinical management, with the early detection of sleep-disordered breathing.
Subject(s)
Diaphragm/physiopathology , Muscular Diseases/physiopathology , Adolescent , Adult , Child , Collagen Type VI/genetics , Collagen Type VI/metabolism , Diagnosis, Differential , Female , Genotyping Techniques , Humans , Immunohistochemistry , Male , Motor Activity/physiology , Muscle Strength/genetics , Muscle Strength/physiology , Muscular Diseases/diagnosis , Muscular Diseases/genetics , Phenotype , Rest/physiology , Severity of Illness Index , Vital Capacity , Young AdultABSTRACT
In neuromuscular disorders beginning in childhood, the involvement of respiratory muscles is common. Deterioration of respiratory function occurs insidiously, contributes to significant morbidity, and is often responsible for mortality. Since symptoms of respiratory involvement are not obvious, especially in the presence of maintained ambulation, respiratory failure must be systematically searched for in order to allow early care. The key to care of respiratory problems in neuromuscular disorders is a preventive approach. Careful monitoring of symptoms, regular assessment of pulmonary function, appropriate presurgical management, and aggressive treatment of respiratory infections must be considered a standard of care.
Subject(s)
Neuromuscular Diseases/therapy , Respiration, Artificial , Respiratory Insufficiency/therapy , Respiratory Muscles/physiopathology , Humans , Neuromuscular Diseases/complications , Neuromuscular Diseases/physiopathology , Respiratory Insufficiency/etiology , Respiratory Insufficiency/physiopathologyABSTRACT
Typical childhood spinal muscular atrophy is a disease that affects the anterior horn of the spinal cord related to SMN1 gene defects. Since no etiological treatment is currently available, its management is necessarily symptomatic and involves multidisciplinary care. The national plan on rare diseases for 2005-2008 developed by the French Ministry of Health resulted in the creation of 12 reference centres for neuromuscular diseases, mainly to improve their diagnosis and management. During the first one-day clinical research meeting on neuromuscular disorders, organized by the French Association to fight myopathies (AFM) in May 2007, clinicians from the 12 national reference centers led workshops for each of the main neuromuscular diseases. Concerning spinal muscular atrophy, discussions involving specialists from medical and allied professions were led by clinicians in charge of the workshop sessions. This paper reports the final version of their recommendation regarding the diagnosis, monitoring and management of typical infantile spinal muscular atrophy, which is necessarily multidisciplinary, including orthopedic, pulmonary, gastroenterology and nutrition care.
Subject(s)
Spinal Muscular Atrophies of Childhood/diagnosis , Spinal Muscular Atrophies of Childhood/surgery , Spinal Muscular Atrophies of Childhood/therapy , Airway Management , Animals , Case Management , Digestive System Diseases/etiology , Digestive System Diseases/therapy , Female , Genetic Counseling , Humans , Monitoring, Physiologic , Orthopedic Procedures , Pain Management , Physical Therapy Modalities , Pregnancy , Pregnancy Complications/therapy , Prenatal Diagnosis , Spinal Muscular Atrophies of Childhood/classification , Spinal Muscular Atrophies of Childhood/epidemiology , Urologic Diseases/etiology , Urologic Diseases/therapyABSTRACT
Acute interstitial nephritis accounts for about 10 % of the cases of acute renal failure. An adverse drug reaction caused by an immunoallergic mechanism is suggested when fever, skin rash, eosinophilia, and eosinophiluria are associated. The outcome is favorable after withdrawal of drug therapy in most cases. We report a case of acute interstitial nephritis induced by immunoallergic drug mechanisms, in a 3-week-old infant who presented with acute renal failure associated with eosinophilia and hepatitis and who had received cefotaxime and gentamicin. The patient's progression was favorable with normalization of renal and liver function 1 week after suspension of antibiotic drugs.
Subject(s)
Anti-Bacterial Agents/adverse effects , Cefotaxime/adverse effects , Gentamicins/adverse effects , Nephritis, Interstitial/chemically induced , Acute Disease , Eosinophilia/chemically induced , Hepatitis/etiology , Humans , Infant, Newborn , MaleABSTRACT
Fukuyama congenital muscular dystrophy (FCMD) is frequent in Japan, due to a founder mutation of the fukutin gene (FKTN). Outside Japan, FKTN mutations have only been reported in a few patients with a wide spectrum of phenotypes from Walker-Warburg syndrome to limb-girdle muscular dystrophy (LGMD2M). We studied four new Caucasian patients from three unrelated families. All showed raised serum CK initially isolated in one case and muscular dystrophy. Immunohistochemical studies and haplotype analysis led us to search for mutations in FKTN. Two patients (two sisters) presented with congenital muscular dystrophy, mental retardation, and posterior fossa malformation including cysts, and brain atrophy at Brain MRI. The other two patients had normal intelligence and brain MRI. Sequencing of the FKTN gene identified three previously described mutations and two novel missense mutations. Outside Japan, fukutinopathies are associated with a large spectrum of phenotypes from isolated hyperCKaemia to severe CMD, showing a clear overlap with that of FKRP.
Subject(s)
Genetic Predisposition to Disease/genetics , Intellectual Disability/genetics , Membrane Proteins/genetics , Muscular Dystrophies/genetics , Mutation/genetics , Nervous System Malformations/genetics , Adult , Atrophy/genetics , Atrophy/pathology , Atrophy/physiopathology , Brain/abnormalities , Brain/pathology , Brain/physiopathology , Child , Creatine Kinase/analysis , Creatine Kinase/blood , DNA Mutational Analysis , Fatal Outcome , Female , Genetic Markers/genetics , Genetic Predisposition to Disease/ethnology , Genotype , Humans , Intellectual Disability/pathology , Intellectual Disability/physiopathology , Male , Muscular Dystrophies/pathology , Muscular Dystrophies/physiopathology , Nervous System Malformations/pathology , Nervous System Malformations/physiopathology , Phenotype , Syndrome , White People , Young AdultABSTRACT
OBJECTIVE: To describe the clinical features of a novel variant of autosomal recessive lower motor neuron disease (LMND) with childhood onset and to map the disease-causing gene. METHODS: The authors performed a clinical study in a large consanguineous African family. After linkage exclusion to SMN1 and SOD1 loci, they performed a genome-wide linkage analysis to map the underlying genetic defect. RESULTS: This novel variant of LMND with childhood onset and autosomal recessive mode of inheritance is characterized by a progressive symmetric and generalized involvement of the musculature. Four of the five affected patients had muscle weakness since age 3, strongly worsening during childhood and leading to generalized tetraplegia in adulthood. Genetic analyses using homozygosity mapping strategy assigned this progressive generalized LMND locus to an interval of 3.9 cM (or 1.5 megabases) on chromosome 1p36, between loci D1S508 and D1S2633 (Z(max) = 3.79 at theta = 0.00 at locus D1S253). This region encloses 27 candidate genes. CONCLUSION: Genetic mapping of a novel rare phenotype of lower motor neuron disease opens the way toward the identification of a new gene involved in motor neuron degeneration, located in the 1p36 chromosomal region.
Subject(s)
Chromosomes, Human, Pair 1 , Genes, Recessive , Genetic Linkage , Motor Neuron Disease/genetics , Adolescent , Adult , Child , Chromosome Mapping/methods , Female , Humans , MaleABSTRACT
Congenital myasthenic syndromes (CMS) are genetic diseases characterized by dysfunctional neuromuscular transmission and usually start during the neonatal period. Most are due to postsynaptic abnormalities, specifically to mutations in the acetylcholine receptor (AChR) genes. In 2002, the group of A Engel reported the first cases of CMS with mutations in the gene coding rapsyn, a postsynaptic molecule which stabilizes AChR aggregates at the neuromuscular junction. Since this first publication, more than 30 other cases, including six in France, have been reported. Study of these published cases allows us to distinguish three classes of phenotypes: 1) severe neonatal cases; 2) more benign cases, starting during infancy; 3) cases with facial malformations, involving Jewish patients originating from the Near-East. Comparison of the observations of other groups with our own has led us to the following conclusions: the N88K mutation is frequent (homozygous in 50% of cases); besides the N88K mutation, the second mutation varies considerably; heterozygous allelic cases (N88K + another mutation) are severe; there is probably a founder effect in the European population. There is phenotypic variability in the homozygous N88K cases, with benign cases and severe cases of early expression. A Engel and colleagues report that the seven cases of benign CMS with facial malformation, previously described in the Jewish population of Iraq and Iran, were caused by mutation in the promoter region of the rapsyn gene.
Subject(s)
Muscle Proteins/genetics , Mutation/genetics , Mutation/physiology , Myasthenic Syndromes, Congenital/genetics , Myasthenic Syndromes, Congenital/physiopathology , Alleles , Child , Child, Preschool , Female , HumansABSTRACT
We studied and conceptually analyzed a retrospective case series of patients with airway compression due to an anterior vertebral body protrusion. The goal was to describe the pathology, methods of management, and a new concept for quantifying deformity. Case reports have been published on this pathology, but there has been no case series to date. In this study 18 patients with ages ranging from 7.3 to 18.0 years had thoracic lordoscoliosis due to a variety of etiologies; most ( n = 10) had a neuromuscular disorder. Following treatment, which most commonly was anterior subtotal subperiosteal vertebral body resection followed by posterior instrumentation and arthrodesis, atelectasia disappeared and any abnormal blood gases normalized; however, the effect on vital capacity was variable. Based on computed tomographic studies, the concept of the deformity as an endothoracic vertebral hump was developed and quantified. Study of this series of patients with compression of the airway due to vertebral body protrusion into the thorax provided the opportunity to describe treatment, define a new concept (the spinal penetration index), and make general recommendations about the management of both the endothoracic hump and the exothoracic rib hump.
Subject(s)
Airway Obstruction/etiology , Lordosis/complications , Radiography, Thoracic/methods , Scoliosis/complications , Tomography, X-Ray Computed , Adolescent , Adult , Airway Obstruction/physiopathology , Airway Obstruction/surgery , Child , Decompression, Surgical , Female , Humans , Imaging, Three-Dimensional , Lordosis/physiopathology , Male , Pulmonary Atelectasis/diagnostic imaging , Pulmonary Atelectasis/etiology , Scoliosis/physiopathology , Vital CapacityABSTRACT
Experience with domiciliary noninvasive mechanical ventilation (NIMV) in children is limited. The aim of this study was to determine the number of patients and categorize the use of domiciliary NIMV in children in France. An anonymous cross-sectional national study was performed, using a postal questionnaire sent to all specialist centers utilizing domiciliary NIMV for chronic respiratory failure. Patients aged <18 years and receiving home NIMV were included in the study. Detailed information was obtained from 102 patients from 15 centers: 4/15 centers cared for 84% of patients; 7% of patients were under 3 years old; 35% were between 4-11 years old; and 58% were older than 12 years. Underlying diagnoses included neuromuscular disease (34%), obstructive sleep apnea (OSA) and/or cranio-facial abnormalities (30%), cystic fibrosis (17%), congenital hypoventilation (9%), scoliosis (8%), and other disorders (2%). NIMV was started because of nocturnal hypoventilation (67%), acute exacerbation (28%), and/or failure to thrive (21%). Volume-targeted ventilation was preferred in restrictive disorders (56%) and central hypoventilation (56%), while pressure support ventilation (PSV) was preferred in cystic fibrosis (71%). Patients with OSA and/or cranio-facial abnormalities were ventilated with continuous positive airway pressure (45%) or bilevel PSV (52%). In conclusion, NIMV is currently used in France for the domiciliary management of children with a variety of conditions causing chronic respiratory failure. However, NIMV in children is still performed on a small scale, and combined with the heterogeneity of the patient population, its application would best be served by centers specializing in the initiation and long-term follow-up of these patients.
Subject(s)
Health Care Surveys/statistics & numerical data , Home Care Services/statistics & numerical data , Respiration, Artificial/statistics & numerical data , Respiratory Insufficiency/therapy , Adolescent , Adult , Age Factors , Child , Child, Preschool , Chronic Disease , Cross-Sectional Studies , Female , France , Humans , Male , Time FactorsABSTRACT
PURPOSE OF THE STUDY: We reviewed retrospectively our patients with thoracic lordoscoliosis and conducted a conceptual analysis of the patients with airway compression and atelectasia due to anterior protrusion of the vertebral bodies in order to describe the pathological conditions involved and the management methods used. Our goal was to develop a new concept for quantifying thoracic deformation. The individual cases discussed here have been reported earlier, but this is the first series analysis to date. MATERIAL AND METHODS: Eighteen patients, aged 7.3 to 18 years, with thoracic lordoscoliosis due to a variety of causes, mostly neuromuscular disorders (12 cases), are described. Most patients were treated by anterior subtotal periosteal resection of the vertebral body followed by posterior instrumentation and arthrodesis. RESULTS: Atelectasia disappeared with a normalization of blood gases but the effect was variable on vital capacity. The analysis of the CT studies led to the concept of spinal deformity as an endothoracic deformation resulting from protrusion of the vertebral body into the thorax, the endothoracic vertebral hump. This concept was developed and quantified leading to the definition of a new index: the spinal penetration index. The spinal penetration index was obtained by tracing a line tangent to the posterior curve of the concave and convex ribs on each CT slice to determine a relationship between the real thoracic surface and theoretical thoracic surface measured with this tangent and the circumference of the thoracic cage. The index was expressed as a percent of the endothoracic surface occupied by the protruding veterbral body and the associated ribs. Calculated for each successive CT slice for the entire height of the thorax yielded a spinal penetration index quantifying the thoracic volume occupied by the spine. For the control population, we used CT series of the thorax obtained to search for pulmonary metastases in patients with malignant tumors. This gave a theoretical volume of 8 to 10% occupied by the spine in normal subjects. In our patients with lordoscoliotic deformations we obtained real volumes of 15, 20 and even 50%. DISCUSSION: The spinal penetration index is an important morphological index of thoracic anatomy that measures the real volume of the functional thoracic cavities and which must be differentiated from vital capacity which measures both volume and function. This index can be used for pre- post-operative comparisons and constitutes a first step in 3-D assessment of thoracic spine deformations. It can also be used to classify spinal deformations and to make general recommendations concerning the management of both endothoracic humps and exothoracic rib humps.
Subject(s)
Scoliosis/pathology , Adolescent , Child , Female , Humans , Male , Radiography , Retrospective Studies , Scoliosis/diagnostic imaging , Severity of Illness Index , Thoracic VertebraeABSTRACT
The congenital muscular dystrophies (CMD) are a heterogeneous group of autosomal recessive disorders presenting in infancy with muscle weakness, contractures, and dystrophic changes on skeletal-muscle biopsy. Structural brain defects, with or without mental retardation, are additional features of several CMD syndromes. Approximately 40% of patients with CMD have a primary deficiency (MDC1A) of the laminin alpha2 chain of merosin (laminin-2) due to mutations in the LAMA2 gene. In addition, a secondary deficiency of laminin alpha2 is apparent in some CMD syndromes, including MDC1B, which is mapped to chromosome 1q42, and both muscle-eye-brain disease (MEB) and Fukuyama CMD (FCMD), two forms with severe brain involvement. The FCMD gene encodes a protein of unknown function, fukutin, though sequence analysis predicts it to be a phosphoryl-ligand transferase. Here we identify the gene for a new member of the fukutin protein family (fukutin related protein [FKRP]), mapping to human chromosome 19q13.3. We report the genomic organization of the FKRP gene and its pattern of tissue expression. Mutations in the FKRP gene have been identified in seven families with CMD characterized by disease onset in the first weeks of life and a severe phenotype with inability to walk, muscle hypertrophy, marked elevation of serum creatine kinase, and normal brain structure and function. Affected individuals had a secondary deficiency of laminin alpha2 expression. In addition, they had both a marked decrease in immunostaining of muscle alpha-dystroglycan and a reduction in its molecular weight on western blot analysis. We suggest these abnormalities of alpha-dystroglycan are caused by its defective glycosylation and are integral to the pathology seen in MDC1C.
Subject(s)
Cytoskeletal Proteins/metabolism , Laminin/deficiency , Membrane Glycoproteins/metabolism , Muscular Dystrophies/congenital , Muscular Dystrophies/genetics , Proteins/chemistry , Proteins/genetics , Adult , Amino Acid Sequence , Base Sequence , Blotting, Western , Child , Child, Preschool , Chromosomes, Human, Pair 19/genetics , Consanguinity , Databases, Nucleic Acid , Dystroglycans , Female , Genotype , Glycosylation , Humans , Immunohistochemistry , Infant , Laminin/genetics , Membrane Proteins , Molecular Sequence Data , Muscle Proteins/analysis , Muscle Proteins/metabolism , Muscular Dystrophies/metabolism , Mutation/genetics , Pedigree , Pentosyltransferases , Polymorphism, Genetic/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Radiation Hybrid MappingABSTRACT
One form of congenital muscular dystrophy, rigid spine syndrome (MIM 602771), is a rare neuromuscular disorder characterized by early rigidity of the spine and respiratory insufficiency. A locus on 1p35-36 (RSMD1) was recently found to segregate with rigid spine muscular dystrophy 1 (ref. 1). Here we refine the locus and find evidence of linkage disequilibrium associated with SEPN1, which encodes the recently described selenoprotein N (ref. 2). Our identification and analysis of mutations in SEPN1 is the first description of a selenoprotein implicated in a human disease.
Subject(s)
Lung Diseases/genetics , Muscle Proteins/genetics , Muscular Dystrophies/genetics , Mutation , Spine/physiopathology , Amino Acid Sequence , Animals , Chromosome Mapping , Chromosomes, Human, Pair 1 , Humans , Molecular Sequence Data , Muscle Proteins/chemistry , Muscular Dystrophies/congenital , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Selenoproteins , Sequence Homology, Amino AcidABSTRACT
OBJECTIVES: Sleep recordings and evoked potentials (EPs) were used in five comatose children to evaluate their predictive value for outcome following a severe comatose state. METHODS AND SUBJECTS: The protocol included EEG, Brainstem Evoked Responses (BERs), Somatosensory Evoked Potentials (SEPs) and polysomnography. From 10 to 15 days post-coma (D10 to D15), EEG and clinical examinations were carried out every second day, then one day in four from 15 to 30 days post-coma (D15 to D30), and one day in seven from D30 to six months (M6). Evoked potentials and Polysomnography were recorded on D10-D15 or D30 in the second month (M2) and in M6. Of the five children, three were in anoxic coma and two in traumatic coma. All had extensive lesions and a Glasgow Coma Scale (GCS) score of less than five. The results of the EEG, polysomnographic and EP recordings were compared to the clinical outcome. RESULTS AND CONCLUSION: In the three anoxic comas we observed BER abnormalities and the absence of SEP N20 associated with wide cortical lesions with brainstem extension. Sleep recordings showed major alterations of the wake-sleep cycle without any improvement in M6. Abnormalities included loss of the normal REM-sleep pattern associated with alteration of NREM sleep and periods of increase in motor activity without EEG arousal. This sleep pattern appeared to be associated with involvement of the brainstem. In the two traumatic comas, alterations of the early cortical SEP responses were less severe and the BERs were normal. Some sleep spindles were observed as well as the persistence of sleep cycles in the first weeks post-coma. The combined use of EEG, EPs and polysomnography improved the outcome prediction in comparison with the use of just one modality. EPs and sleep recordings were far superior to clinical evaluation and to GCS in the appreciation of the functional status of comatose children. The reappearance of sleep patterns is considered to be of favorable prognosis for outcome of the coma state, as is the presence of sleep spindles in post-trauma coma. This study showed that EPs and sleep recordings help to further distinguish between patients with good or bad outcomes.
Subject(s)
Brain Damage, Chronic/diagnosis , Coma/physiopathology , Evoked Potentials , Polysomnography , Sleep Wake Disorders/etiology , Brain Damage, Chronic/etiology , Brain Edema/etiology , Brain Injuries/complications , Cerebellar Ataxia/etiology , Cerebral Hemorrhage/complications , Child , Child, Preschool , Coma/etiology , Dehydration/complications , Electroencephalography , Female , Glasgow Coma Scale , Heart Arrest/etiology , Humans , Hypoxia, Brain/etiology , Hypoxia, Brain/physiopathology , Male , Near Drowning/complications , Persistent Vegetative State/diagnosis , Persistent Vegetative State/etiology , Prognosis , Quadriplegia/etiology , Sleep Wake Disorders/diagnosis , Sleep Wake Disorders/physiopathologyABSTRACT
Multi-minicore disease (MmD) is a congenital myopathy morphologically defined by the presence of multiple small zones of sarcomeric disorganization and lack of oxidative activity ("minicores") in muscle fibers. The dinical expression of MmD is considered to be greatly variable, and the morphological lesions are nonspecific; therefore, its boundaries are poorly defined, and its molecular bases are not known. To better define the phenotypic characteristics of MmD, we analyzed a large series of 38 patients with multiple minicores in muscle fibers in the absence of any other potential cause. According to clinical features, 4 subgroups were identified. Most patients (30 cases) shared a common highly consistent phenotype marked by the axial predominance of muscle weakness and a high occurrence of severe respiratory insufficiency and scoliosis ("classical" form). Other forms were characterized by pharyngolaryngeal involvement and total lack of head control (2 cases), antenatal onset with arthrogryposis (3 cases), and slowly progressive weakness with marked hand amyotrophy (3 cases). Type 1 fiber predominance and hypotrophy as well as centrally located nuclei were found in every subgroup. MmD is thus phenotypically heterogeneous, but a typical recognizable phenotype does exist. This phenotype classification should be helpful when undertaking research into the molecular defects that cause MmD.
Subject(s)
Muscles/pathology , Muscular Diseases/genetics , Muscular Diseases/pathology , Biopsy , Female , Humans , Male , Phenotype , Retrospective StudiesABSTRACT
Rigid spine syndrome is a neuromuscular disorder characterised by early rigidity of the spine due to axial muscle contractures, generally associated with muscle weakness, limb-joint contractures, and often respiratory failure. This phenotype may be associated with several muscular diseases. In cases of merosin-positive congenital muscular dystrophies (CMD) with rigid spine syndrome, we have recently identified a new locus (RSMD1) on chromosome 1p35-36. In the present study, we report the clinical, morphological and genetic analysis of other patients affected by a CMD with rigid spine syndrome from nine consanguineous families. Homozygosity mapping showed that the disease was linked to RSMD1 in one of the nine families. The other families were excluded from RSMD1, and the patients presented highly variable phenotypes suggesting the involvement of more than one gene defect in rigid spine syndrome. Nevertheless, a subgroup of patients who never walked, and had very early rigidity of the spine and scoliosis, may be considered for further genetic analysis.
Subject(s)
Chromosomes, Human, Pair 1 , Muscle Rigidity/genetics , Muscular Dystrophies/genetics , Scoliosis/genetics , Spinal Diseases/genetics , Adult , Age of Onset , Biopsy , Child , Chromosome Mapping , Consanguinity , DNA/blood , DNA/genetics , Female , Homozygote , Humans , Male , Muscle Rigidity/pathology , Muscular Dystrophies/complications , Muscular Dystrophies/pathology , Nuclear Family , Pedigree , Scoliosis/complications , Spinal Diseases/pathology , SyndromeABSTRACT
The SMN1 gene is homozygously deleted for at least exon 7, interrupted or converted to a non-functional telomeric copy in most cases of proximal spinal muscular atrophies. The presence of a pseudogene hampers direct detection of the exon 7 deletion. We describe a method for the detection of the of exon 7 deletion, based on the amplification refractory mutation system (ARMS), in a multiplex PCR with fluorescent-labelled primers. The gene and pseudogene amplification products differ in the dye bound and in their size, which allows distinction of both products on electrophoresis. The pseudogene is used as an internal control, and this method gives a clear and specific pattern for the patients. Amplification is achieved with 30 cycles, and specificity is retained up to 40 cycles.
Subject(s)
Alleles , Genes, Recessive , Muscular Atrophy, Spinal/diagnosis , Polymerase Chain Reaction/methods , Base Sequence , DNA Primers , Fluorescent Dyes , Humans , Muscular Atrophy, Spinal/geneticsABSTRACT
Classical congenital muscular dystrophy with merosin deficiency is caused by mutations in the laminin alpha2 chain gene (LAMA2). Extended sequencing of the introns flanking the 64 LAMA2 exons was carried out and, based on these sequences, oligonucleotide primers were designed to amplify the coding region of each exon separately. By PCR-SSCP analysis, we identified eight new mutations in nine families originating from various countries. All induced a premature truncation of the protein, either in the short arm or in the globular C-terminal domain. A 2 bp deletion in exon 13, 2098delAG, was found in three French non-consanguineous families and a nonsense mutation of exon 20, Cys967stop, in two other non-consanguineous families originating from Italy. Determination of rare intragenic polymorphisms permitted us to show evidence of founder effects for these two mutations suggesting a remote degree of consanguinity between the families. Other, more frequent polymorphisms, G to A 1905 (exon 12), A to G 2848 (exon 19), A to G 5551 (exon 37), and G to A 6286 (exon 42), were used as intragenic markers for prenatal diagnosis. This study provides valuable methods for determining the molecular defects in LAMA2 causing merosin deficient congenital muscular dystrophy.
Subject(s)
Founder Effect , Laminin/genetics , Muscular Dystrophies/genetics , Prenatal Diagnosis , Child , DNA Mutational Analysis , DNA Primers , Exons , Female , Haplotypes , Humans , Introns , Male , Microsatellite Repeats , Muscular Dystrophies/congenital , Muscular Dystrophies/diagnosis , Mutation , Pedigree , Polymerase Chain Reaction , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , Sequence Analysis, DNAABSTRACT
PURPOSE: To evaluate the brain magnetic resonance (MR) imaging findings in patients with the "classic" form of congenital muscular dystrophy (patients with normal intelligence) in relation to the absence of merosin, a recently identified molecular component in the basement membrane of muscle fiber. MATERIALS AND METHODS: Brain MR images in 15 patients (13 children, two adults) were reviewed and correlated with the patient's merosin status. Merosin was evaluated by means of immunocytochemical study of specimens from muscle biopsy. RESULTS: Nine patients had merosin deficiency. All patients had diffuse white matter alterations similar to those seen in cases of leukodystrophy. Periventricular and subcortical white matter were involved. The corpus callosum and internal capsule were spared. Follow-up MR images were available in two patients; changes were nonprogressive. White matter signal intensity was normal in the six patients with normal uniform labeling against merosin. Ventricular dilatation and cortical atrophy were observed in both groups. CONCLUSION: Diffuse white matter changes resembling those seen with leukodystrophy may be a valuable criterion for diagnosis of merosin deficiency in patients with classic congenital muscular dystrophy.
Subject(s)
Brain/pathology , Laminin/deficiency , Magnetic Resonance Imaging , Muscle Fibers, Skeletal/chemistry , Muscular Dystrophies/congenital , Adult , Biopsy , Child , Female , Humans , Male , Muscle, Skeletal/pathology , Muscular Dystrophies/metabolism , Muscular Dystrophies/pathologyABSTRACT
A selective deficiency of a specific laminin isovariant, merosin made of M, B1 and B2 chains, was found in a series of 17 patients affected with congenital muscular dystrophy (CMD). The merosin deficiency was complete in 15 cases, and almost complete in two cases. An overexpression of the laminin A chain was seen in these biopsies, while B1 and B2 chains were normally expressed. Comparison of the clinical data with a series of 18 "merosin-non deficient" cases showed that the "merosin-deficient" cases were forming a more homogenous group than the "non-deficient" one. Hypotonia, contractures, motor development delay were generally more severe in the "merosin-deficient" series of cases. Moreover, white matter alterations were seen in most cases explored by MRI or scan imaging. A genetic linkage with a 6q2 locus, corresponding to the M chain gene localization, was found in a panel of informative families from French and Turkish origin with "merosin deficient" CMD. "Merosin non-deficient" families did not map on this locus. So, the "merosin-deficient" CMD can be considered as a peculiar entity within the group of Congenital Muscular Dystrophies.